25 pieces — research, policy, clinics, and the treatment experience. Written from the inside.
Beond is the most-searched ibogaine clinic in the US, by a wide margin. Here's the independent answer to what it actually is — including the parts the marketing won't tell you.
A peer-reviewed neuroimaging study showed measurable changes in how veterans' brains function after ibogaine. It helps explain why ibogaine works on TBI in ways that drugs and therapy can't.
Mississippi legalized ibogaine for therapeutic use with near-unanimous bipartisan support. What the law actually does, what it doesn't do, and why the vote count matters.
SR-17018 is being sold direct-to-consumer as a 10-day kratom "receptor reset." What the compound actually is, what's not known, why the science is interesting, and why the ibogaine field is watching.
Beond is the most-searched ibogaine clinic in the US. An honest, independent primer on what the clinic is, what it costs, and who it fits, including the parts the marketing won't tell you.
Before there was a molecule, there was a shrub in a Gabonese rainforest. What ibogaine is, where it comes from, who found it first, and how it gets to a clinic today.
Chemists have spent years engineering ibogaine derivatives that strip out the hallucinations and cardiac risk. Three compounds are furthest along. None of them have settled the most important question about whether the experience itself is the therapy.
A peer-reviewed neuroimaging study showed measurable changes in how veterans' brains function after ibogaine treatment. It helps explain why ibogaine works on TBI in ways that drugs and therapy can't. Almost no one covered it.
Schedule I is supposed to mean two things: high potential for abuse, no accepted medical use. For ibogaine, both are arguable. What the designation actually does, why ibogaine ended up under it, and what would have to happen to move it.
The Bwiti of Gabon figured out iboga's safety, dosing, and capacity to heal. They did it empirically, centuries before Western medicine met the molecule. The ethnobotanical context the science still largely ignores.
A deep-red state legislature just passed a Schedule I psychedelic bill 161 to 2. Almost no one outside the state covered it. Why it happened in Mississippi, and what it tells us about which state acts next.
Most people planning an ibogaine session don't think to ask whether it will be private. Here's why the format matters more than you might expect, and why most experienced clinics default to the solo room.
Most people research ibogaine for months and spend almost no time thinking about what comes after. Integration isn't optional — it's where the gains are protected or lost. Here's what it actually involves.
Psilocybin, ketamine, MDMA, ayahuasca — ibogaine is often lumped in with all of them. It shouldn't be. The mechanism, the experience, the risk profile, and the clinical use cases are fundamentally different.
More and more clinics offer ibogaine followed by 5-MeO-DMT a few days later. Here's the honest explanation: what each medicine does, why they complement each other, and what the research actually says about the combination.
Buprenorphine (Suboxone) and methadone are the most common MAT medications — and they require special protocols before ibogaine treatment. Not a disqualifier. But a process that takes planning.
Ibogaine treatment typically runs $7,000 to $17,000+. The spread is wide because what's included varies enormously. Here's what drives the price, what the tiers look like in practice, and what questions to ask before you wire anything.
There have been deaths associated with ibogaine. Anyone honest about this medicine leads with that. But the record also shows that the vast majority occurred in specific, preventable circumstances. Here's what the data actually says.
Yes — with the wrong cardiac profile, at the wrong dose, with the wrong drug in your system. But that's not the whole answer. The honest answer requires distinguishing between inherent risk and contextual risk. Here's what the evidence says.
Treatment-resistant PTSD isn't just "hard to treat." It's a clinical designation that means the standard protocol has failed. Here's what that means, why it happens so often in veterans, and what's being used outside the VA system.
Traumatic brain injury and PTSD almost always co-occur in combat veterans. The Stanford study treated both. Here's what the imaging data shows about ibogaine's effect on TBI-damaged brains, and why researchers think neuroplasticity is the mechanism.
Ibogaine has real drug interactions — some dangerous, some that just interfere with the experience. This is the complete list: what to stop, why, and the minimum washout window for each category before treatment begins.
Ibogaine treatment costs $7,000 to $14,000. The VA won't cover it. Tricare won't cover it. But several nonprofits exist specifically to help veterans access it through grants and scholarships. Here's what's available and how each one works.
Iboga and ibogaine aren't the same thing. Here's the difference between the whole plant and the isolated alkaloid, the ceremonial and clinical settings — and how to decide which path is right for you.
If someone you love is going to Mexico for ibogaine, here's what you need to know — what to expect, what to do, and what not to do before, during, and after. From someone whose family has been through it.
Ibogaine's cardiac risk is real — and manageable with proper screening. Here's exactly what the screening involves, who gets screened out, and what to do if you have cardiac concerns before you start.
Not all ibogaine clinics in Mexico are equal. Some have had deaths. Here's what separates a safe, legitimate operation from one that's cutting corners — and the questions to ask before you commit.
An honest, first-person account of what an ibogaine session actually involves — the timeline, the experience, what's hard, and what the other side looks like. Not marketing. Just the truth.
Both are getting serious attention as psychedelic treatments. They work differently, on different problems, with different risk profiles. Here's the real comparison — and who each one is actually right for.
Veterans are quietly bypassing the VA and paying out of pocket for ibogaine in Mexico. Here's what the data says, what the VA actually offers, and why thousands are making that choice.
30 special operations veterans. Severe, treatment-resistant PTSD and TBI. Published in Nature Medicine. Most coverage reduces it to a single headline — here's what they actually measured, what the results mean, and what the study's limitations are.
Ibogaine was discovered to interrupt addiction in 1962 — by accident. Sixty years later, the science finally explains why: five distinct mechanisms that reset the brain's reward system at a level that no existing medication or therapy reaches.
Trump signed an executive order on April 18 directing $50M toward ibogaine research and fast-tracking FDA review. Here's what the EO actually does, why it matters — and why veterans who are ready right now don't have to wait for Washington to catch up.
No articles in this section yet.